Robert B. Royds
Keine laufenden Positionen mehr
Karriereverlauf von Robert B. Royds
Ehemalige bekannte Positionen von Robert B. Royds
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| The Royal College of Physicians | Geschäftsführer | - | 10.06.2011 |
| Corporate Officer/Principal | 10.06.2011 | 23.03.2013 | |
| Theradex Systems, Inc. | Vorsitzender | 19.08.2009 | 23.03.2013 |
| Gründer | - | 23.03.2013 | |
| LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Direktor/Vorstandsmitglied | 06.05.2011 | 23.03.2013 |
| Gründer | 24.05.2005 | 23.03.2013 | |
| Merck Sharp & Dohme Research Laboratories | Corporate Officer/Principal | - | - |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - | - |
Snowdon, Inc.
 Snowdon, Inc. Pharmaceuticals: MajorHealth Technology Snowdon, Inc. operates as a drug discovery and development company. The firm creates and distributes computational tools and techniques for the life sciences including drug discovery and development, safety, toxicity assessment and environmental and toxicological surveillance. It provides a solution to the problems of efficiency and productivity in drug discovery by integrating an array of advanced tools with proprietary information technology to more efficiently discover new drugs and harness the flood of new disease-related protein targets presented by genomics. The company was founded by William J. Welsh and Susan M. Welsh in 2007 and is headquartered in Princeton, NJ. | Direktor/Vorstandsmitglied | - | - |
Ausbildung von Robert B. Royds
| University of London | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
| Vereinigtes Königreich | 3 |
Operativ
| Corporate Officer/Principal | 3 |
| Director/Board Member | 2 |
| Founder | 2 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Snowdon, Inc.
Snowdon, Inc. Pharmaceuticals: MajorHealth Technology Snowdon, Inc. operates as a drug discovery and development company. The firm creates and distributes computational tools and techniques for the life sciences including drug discovery and development, safety, toxicity assessment and environmental and toxicological surveillance. It provides a solution to the problems of efficiency and productivity in drug discovery by integrating an array of advanced tools with proprietary information technology to more efficiently discover new drugs and harness the flood of new disease-related protein targets presented by genomics. The company was founded by William J. Welsh and Susan M. Welsh in 2007 and is headquartered in Princeton, NJ. | Health Technology |
| Theradex Systems, Inc. | |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
| Merck Sharp & Dohme Research Laboratories |
- Börse
- Insiders
- Robert B. Royds
- Erfahrung
